PROTAC eEF2K degrader-2

PROTAC eEF2K degrader-2 is a CRBN-recruiting eEF2K degrader (DC50 values of 0.88 and 0.67 μM in MDA-MB-231 and HCC1806 TNBC cells, respectively). PROTAC eEF2K degrader-2 binds to the thalidomide (Thalidomide) (HY-14658) binding domain of CRBN , forming an eEF2K-CRBN ternary complex, promoting eEF2K polyubiquitination and proteasomal degradation, and inhibiting eEF2 phosphorylation. PROTAC eEF2K degrader-2 induces apoptosis and inhibits EMT, cell migration, proliferation, colony formation, and TNBC organoid growth. PROTAC eEF2K degrader-2 can be used for research on triple-negative breast cancer.
(Pink: CaMK III/eEF-2K ligand (HY-188621); Blue: Cereblon ligand (HY-10984); Black: linker).

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • CAS No.: 3070364-13-2
  • Formule: C39H47N7O9
  • Masse moléculaire:757.83
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Activité biologique
  • Chemical Information
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00